未登录

H

Huyang Xie

fudan university

H指数:15

被引数:1,059

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Identification of the gene signatures related to NK/T cell communication to evaluate the tumor microenvironment and prognostic outcomes of patients with prostate adenocarcinoma

鉴定与NK/T细胞通讯相关的基因特征，以评估前列腺腺癌患者的肿瘤微环境及预后结局。

FRONTIERS IN IMMUNOLOGY

IF5.9

2025-04-160

OA

Tumor-associated Macrophage-derived Interleukin-23 Interlinks Kidney Cancer Glutamine Addiction with Immune Evasion (vol 75, pg 752, 2019)

EUROPEAN UROLOGY

IF25.2

2024-01-010

PRE

Association of radioactive iodine treatment in differentiated thyroid cancer and cardiovascular death: a large population-based study

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION

IF3.5

2023-08-061

PRE

Development and External Validation of a Novel 12-Gene Signature for Prediction of Overall Survival in Muscle-Invasive Bladder Cancer

FRONTIERS IN ONCOLOGY

IF3.3

2019-09-0617

OAAI

Retinoic Acid-Related Orphan Receptor C Regulates Proliferation, Glycolysis, and Chemoresistance via the PD-L1/ITGB6/STAT3 Signaling Axis in Bladder Cancer

CANCER RESEARCH

IF16.6

2019-05-15100

OAAI

Tumor-associated Macrophage-derived Interleukin-23 Interlinks Kidney Cancer Glutamine Addiction with Immune Evasion

肿瘤相关巨噬细胞衍生的Interleukin-23将肾癌谷氨酰胺成瘾与免疫逃避联系起来

EUROPEAN UROLOGY

IF25.2

2019-05-01147

PREAI

Tumor stroma-infiltrating mast cells predict prognosis and adjuvant chemotherapeutic benefits in patients with muscle invasive bladder cancer

IF6.3

2018-08-0162

OAAI

Identification and Validation of Stromal Immunotype Predict Survival and Benefit from Adjuvant Chemotherapy in Patients with Muscle-Invasive Bladder Cancer

CLINICAL CANCER RESEARCH

IF10.2

2018-07-01122

OAAI

B4GALT1 expression predicts prognosis and adjuvant chemotherapy benefits in muscle-invasive bladder cancer patients

IF3.4

2018-05-2418

OAAI

The Oncogenic Role of COL23A1 in Clear Cell Renal Cell Carcinoma (vol 7, 2017)

SCIENTIFIC REPORTS

IF3.9

2018-04-125

OAAI

Prognostic and Predictive Value of O6-methylguanine Methyltransferase for Chemotherapy in Patients with Muscle-Invasive Bladder Cancer

ANNALS OF SURGICAL ONCOLOGY

IF3.5

2017-11-074

PREAI

The Oncogenic Role of COL23A1 in Clear Cell Renal Cell Carcinoma

SCIENTIFIC REPORTS

IF3.9

2017-08-2927

OAAI

High CXC chemokine receptor 1 level represents an independent negative prognosticator in non-metastatic clear-cell renal cell carcinoma patients

IF6.3

2017-08-0814

OAAI

THE B4GALT1 EXPRESSION IS PROGNOSTIC AND PREDICTIVE FOR POSTOPERATIVE ADJUVANT CHEMOTHERAPY BENEFIT IN PATIENTS WITH MUSCLE-INVASIVE BLADDER CANCER

JOURNAL OF UROLOGY

IF6.8

2017-04-010

OAAI

INCREASED B4GALT7 EXPRESSION IS ASSOCIATED WITH ADVERSE ONCOLOGIC OUTCOME IN LOCALIZED CLEAR CELL RENAL CELL CARCINOMA

JOURNAL OF UROLOGY

IF6.8

2017-04-010

PREAI

DEVELOPMENT AND EXTERNAL VALIDATION OF A NOVEL 12-GENE SIGNATURE ON MUSCLE-INVASIVE BLADDER CANCER FOR PREDICTION OF OVERALL SURVIVAL: LINKAGE TO DATA FROM THE CANCER GENOME ATLAS

JOURNAL OF UROLOGY

IF6.8

2017-04-010

PREAI

A CIRCULAR RNA (CIRCLPAR1) AS A NOVEL BIOMARKER OF PROGNOSIS FOR BLADDER CANCER

JOURNAL OF UROLOGY

IF6.8

2017-04-010

PREAI

Expression of ARID1B Is Associated With Poor Outcomes and Predicts the Benefit from Adjuvant Chemotherapy in Bladder Urothelial Carcinoma

JOURNAL OF CANCER

IF3.2

2017-01-0116

OAAI

Tumor Infiltrating Mast Cells (TIMs) Confers a Marked Survival Advantage in Nonmetastatic Clear-Cell Renal Cell Carcinoma

ANNALS OF SURGICAL ONCOLOGY

IF3.5

2016-11-2839

PREAI

INCREASED B4GALT1 EXPRESSION IS ASSOCIATED WITH ADVERSE ONCOLOGIC OUTCOMES IN LOCALIZED CLEAR CELL RENAL CELL CARCINOMA

JOURNAL OF UROLOGY

IF6.8

2016-04-010

OA